RecruitingNCT05830279
Pharmacogenetic recommendations for medication care in people with cancer
About this title
Read the official source — NCT05830279Observational studyAges 18+CanadaDepression
Understand this study
Who could participate?
Listed age limits: from 18 years.
- Listed locations
- LondonSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: May 1, 2023
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 600
- Sponsor
- London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- Sponsor type
- Research institute
- Study type
- Observational
- Intervention type
- Genetic, Other
- Locations
- Canada
- Age range
- Over 18 Years
- Official registry ID
- NCT05830279
- Official title
Show the full official title
Evaluating the Implementation of Personalized Medicine for Optimal Drug Therapy in Cancer Patients: A Prospective Longitudinal Trial
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
London
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's, a research institute.
Who can participate?
Listed age limits: from 18 years.
Is this study still recruiting?
The registry lists this study as recruiting.
